M. D. Squire et al. / Tetrahedron: Asymmetry 13 (2002) 1849–1854
1853
2.54 (dd, J=7.6, 5.2 Hz, 1H), 2.67–2.76 (m, 2H), 3.57
(t, J=4.8 Hz, 2H); 13C NMR: l 12.1, 20.5, 20.5, 27.2,
36.9, 39.1, 45.0, 46.6, 48.4, 49.8, 61.0, 66.4; IR (Nujol):
3320, 3176, 1067 cm−1. Anal. calcd for C12H23NO: C,
73.04; H, 11.75; N, 7.10. Found: C, 72.80; H, 11.89; N,
7.25%.
3066, 1420, 1361, 1081, 757, 704 cm−1. Anal. calcd for
C19H28N2O2: C, 72.12; H, 8.92; N, 8.85. Found: C,
72.15; H, 9.13; N, 8.94%.
Acknowledgements
4.4.2. (1R,1%R,2%S,4%R)-2-Phenyl-2-(1,7,7-trimethylbicy-
clo[2.2.1]hept-2-ylamino)ethanol, 11b. 82% yield as col-
orless crystals; mp 76–77°C (hexanes); [h]D=−26.0 (c 1,
We gratefully acknowledge support from the depart-
ment of chemistry of Illinois State University, Merck &
Co, Inc. We also thank the donors of the Petroleum
Research Fund administered by the American Chemical
Society for partial support of this research.
1
MeOH); H NMR: l 0.56 (dd, J=12.8, 4.4 Hz, 1H),
0.78 (s, 3H), 0.83 (s, 3H), 0.89 (s, 3H), 1.09 (ddd, J=9.2
Hz, 4.4 Hz, 4.4 Hz, 1H), 1.27–1.35 (m, 1H), 1.51 (t,
J=4.4 Hz, 1H), 1.63–1.72 (m, 1H), 1.76–1.82 (m, 1H),
1.97–2.05 (m, 1H), 2.83 (ddd, J=10.0, 4.4, 1.6 Hz, 1H),
3.47 (dd, J=10.4, 8.4 Hz, 1H), 3.67 (dd, J=10.4, 4.4
Hz, 1H), 3.75 (dd, J=8.0, 4.4 Hz, 1H), 7.25–7.36 (m,
5H); 13C NMR: l 14.3, 18.5, 19.8, 27.3, 28.4, 39.5, 45.1,
17.9, 49.3, 61.7, 64.7, 65.9, 127.0, 127.4, 128.5, 142.3;
IR (Nujol): 3285, 3155, 3060, 3025, 1042 cm−1. Anal.
calcd for C18H27NO: C, 79.07; H, 9.95; N, 5.12. Found:
C, 79.11; H, 10.04; N, 5.31%.
References
1. ‘Chiral Pharmaceuticals’: Stinson, S. C. Chem. Eng. News
2001, 79, 79–97.
2. (a) Delogu, G.; Fabbri, D.; de Candia, C.; Patti, A.;
Pedotti, S. Tetrahedron: Asymmetry 2002, 13, 891; (b)
Zhou, H.; Lu, S.; Xie, R.; Chan, A. S. C.; Yang, T.-K.
Tetrahedron Lett. 2001, 42, 1107; (c) Santhi, V.; Rao, J.
M. Synth. Commun. 2000, 30, 4329; (d) Altava, B.;
Burguete, M. I.; Garc´ıa Verdugo, E.; Luis, S. V.; Pozo,
O.; Salvador, R. V. Eur. J. Org. Chem. 1999, 2263; (e)
Reiners, I.; Wilken, J.; Martens, J. Tetrahedron: Asymme-
try 1995, 6, 3063; (f) Kim, H. Y.; Park, D. H.; B., I. S.;
Yoon, I. K.; Park, C. S. J. Org. Chem. 1993, 58, 4511.
3. (a) Garc´ıa Martinez, A.; Teso Vilar, E.; Garc´ıa Fraile, A.;
de la Moya Cerero, S.; Mart´ınez-Ruiz, P.; Chicharro
Villas, P. Tetrahedron: Asymmetry 2002, 13, 1; (b) Dim-
itrov, V.; Dobrikov, G.; Genov, M. Tetrahedron: Asym-
metry 2001, 12, 1323; (c) Orsini, F.; Sello, G.; Bestetti, G.
Tetrahedron: Asymmetry 2001, 12, 2961; (d) Garc´ıa Mar-
tinez, A.; Teso Vilar, E.; Garc´ıa Fraile, A.; de la Moya
Cerero, S.; Mart´ınez-Ruiz, P. Tetrahedron: Asymmetry
1998, 9, 1737; (e) Przeslawski, R. M.; Newman, S.;
Thornton, E. R.; Joullie, M. M. Synth. Commun. 1995,
25, 2975; (f) Noyori, R.; Kitamura, M. Angew. Chem.,
Int. Ed. Engl. 1991, 30, 49; (g) Kouklovsky, C.; Pouihes,
A.; Langlois, Y. J. Am. Chem. Soc. 1990, 112, 6672.
4. (a) Seyden-Penne, J. Chiral Auxiliaries and Ligands in
Asymmetric Synthesis; John Wiley & Sons: New York,
1995; (b) Koskinen, A. Asymmetric Synthesis of Natural
Products; John Wiley & Sons: New York, 1993.
5. (a) Hitchcock, S. R.; Nora, G. P.; Casper, D. M.; Squire,
M. D.; Maroules, C. D.; Ferrence, G. M.; Szczepura, L.
F.; Standard, J. M. Tetrahedron 2001, 57, 9789; (b)
Hitchcock, S. R.; Casper, D. M.; Nora, G. P.; Blackburn,
J. R.; Bentley, J. T.; Taylor, D. C. J. Heterocycl. Chem.
2002, 39, 823.
6. (a) Page, P. C. B.; Murrell, V. L.; Limousin, C.; Laffan,
D. D. P.; Bethell, D.; Slawin, A. M. Z.; Smith, T. A. D.
J. Org. Chem. 2000, 65, 4204; (b) Morris, D. G.; Ryder,
K. S. Synthesis 1997, 620; (c) Guziec, F. S., Jr.; Russo, J.
M. Synthesis 1984, 479; (d) Bondavalli, F.; Schenone, P.;
Ranise, A. Synthesis 1979, 830.
4.4.3. (1R,1%R,2S,2%S,4%R)-1-Phenyl-2-(1,7,7-trimethylbi-
cyclo[2.2.1]hept-2-ylamino)propan-1-ol, 11c. 88% yield as
colorless crystals; mp 47–48°C (hexanes); [h]D=−31.3 (c
1, MeOH); 1H NMR: l 0.77 (d, J=6.8 Hz, 3H), 0.84 (s,
3H), 0.93 (s, 3H), 0.94 (s, 3H), 1.09 (AB spin system,
J=18.8, 8.4 Hz, 2H), 1.50–1.59 (m, 2H), 1.68–1.73 (m,
2H), 1.81 (dd, J=12.8, 8.8 Hz, 1H), 2.63 (dd, J=8.4,
4.4 Hz, 1H), 2.94 (dq, J=6.8, 4.0 Hz, 1H), 4.017 (bs,
1H), 4.68 (d, J=4.4 Hz, 1H), 7.21–7.45 (m, 5H); 13C
NMR: l 12.7, 16.1, 20.5, 20.6, 27.2, 37.0, 41.1, 45.1,
16.7, 48.4, 57.5, 64.0, 72.5, 126.0, 126.8, 127.9, 141.4;
IR (KBr): 3416; 3062, 3028 cm−1. Anal. calcd for
C19H29NO: C, 79.39; H, 10.17; N, 4.87. Found: C,
79.40; H, 10.07; N, 5.08%.
4.4.4.
(1R,1%R,2S,2%S,4%R)-2-(1,7,7-trimethylbicy-
clo[2.2.1]hept-2-yl-N-nitrosoamino)-1-phenylpropan-1-ol,
12. Amine 11c (11.8 g, 41.1 mmol) was dissolved in
THF (18 mL) and to this solution was added sodium
nitrite (3.12 g, 45.2 mmol) followed by the cautious
addition of an aqueous solution of HCl (2.74 M, 17.3
mL, 47.3 mmol). The reaction was stirred overnight
and was quenched by the addition of a saturated
aqueous solution of sodium bicarbonate (100 mL). The
N-nitrosamine product was extracted from this mixture
by the use of ethyl acetate (2×100 mL). The combined
organic layers were treated with a saturated aqueous
solution of brine (100 mL), dried (MgSO4) and the
solvent was removed by rotary evaporation to afford
the title compound as yellow crystals in nearly quanti-
tative yield. A small sample was recrystallized from
pure hexanes for characterization: mp 118.5–120°C
1
(hexanes); [h]D=+180 (c 5, MeOH); H NMR: l 0.54–
0.59 (m, 1H), 0.55 (s, 3H), 0.73 (s, 3H), 0.76 (s, 3H),
0.99–1.05 (m, 1H), 1.45–1.50 (m, 1H), 1.56–1.68 (m,
2H), 1.70 (d, J=6.8 Hz, 3H), 2.59 (d, J=2.4 Hz, 1H),
4.25–4.37 (m, 3H), 5.05 (dd, J=6.0, 2.0 Hz, 1H),
7.24–7.36 (m, 5H); 13C NMR: l 10.2, 11.5, 13.0, 17.9,
20.2, 20.3, 26.3, 31.8, 35.9, 38.5, 44.4, 46.3, 52.5, 59.9,
63.1, 78.1, 126.3, 127.8, 128.2, 141.3; IR (KBr): 3356,
7. (R)-(−)-Phenylglycinol was obtained by reduction of
commercially available (R)-phenylglycine. See: (a)
McKennon, M. J.; Meyers, A. I.; Drauz, K.; Schwarm,
M. J. Org. Chem. 1993, 58, 3568; (b) Kanth, J. V. B.;
Periasamy, M. J. Org. Chem. 1991, 56, 5964; (c) The